medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2010, Number 3

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2010; 8 (3)

Botriomycosis: A paediatric and an adult case

Cubilla E, Guzmán A, González A, Mendoza G, Aguilar G, García RMT, Arenas R

Language: Spanish
References: 32
Page: 187-191
PDF size: 837.95 Kb.


ABSTRACT

Botryomycosis is a bacterial infection and Staphylococcus aureus is its most common etiological agent. It can involve cutaneous or internal organs with nodules, abscesses or fistulae, with a chronic, recurring course and a typical poor response to treatment even with prolonged antibiotic courses. We report 2 cases caused by S. aureus in a 38 year-old female and in a 13 year-old boy; both with excellent response to treatment.


REFERENCES

  1. Bonifaz A, Carrasco E. “Botryomycosis”. Int J Dermatol 1996; 35: 381-388.

  2. Arenas R. Micología Médica Ilustrada. México, McGraw-Hill 2008: 292- 295

  3. Arenas R. “Botriomicosis”. Micología Médica Ilustrada. México, McGraw Hill, 2008, 26: 292-295.

  4. Rippon JW. “Botryomycosis”. En: Medical Mycology. The pathogenic fungi and the pathogenic actinomycetes. 3a ed, Philadelphia, Saunders, 1988: 116.

  5. Neafie RC, Marty AM. “Unusual infections in humans”. Clin Microbiol Rev 1993; 6 (1): 34-56.

  6. Hacker P. “Botryomycosis”. Int J Dermatol 1983; 22: 455-458.

  7. Findlay GH, Vismer HF. “Botryomycosis: some African cases”. Int J Dermatol 1990; 29: 340-344.

  8. Silvaraj S, Muthu Sekhar MR, Baig MF. “Micrococcal botryomycosis of the left temporal region”. Indian J Dent Res 2007; 18 (3): 131-134.

  9. Feldman SR, Hill Ch, Petersen MJ. “Botryomycosis caused by Moraxella noliquefaciens”. Cutis 1989; 43: 140-142.

  10. Jucgla A, Sais G, Carratala J, Moreno A, Fernandez-Sevilla A, Peyri J. “A papular eruption secondary to infection with Corynebacterium jeikeium with histopathological features mimicking botryomycosis”. Br J Dermatol 1995; 133 (5): 801-804.

  11. Calegari L, Gezuele E, Torres E, Carmona C. “Botryomycosis caused by Pseudomonas vesicularis”. Int J Dermatol 1996; 35: 817-818.

  12. Prado de Oliveira ZN, Cuce LC, Salebian A. “Botryomycosis”. Med Cutan Ibero Lat Am 1986; 14: 49-54.

  13. Simantov A, Chosidow O, Fraitag S y cols. “Disseminated cutaneous botryomycosis, an unexpected diagnosis after 20 years duration”. Clin Exp Dermatol 1994, 19: 259-261.

  14. Martín-Pascual A, Pérez AG. “Botryomycosis”. Dermatológica 1975; 151: 302-309.

  15. Brunken RC, Lichon-Chao N, Broek HV. “Immunologic abnormalities in botryomycosis. A case report with review of the literature”. J Am Acad Dermatol 1983, 9: 428-434.

  16. Bridgeford EC Fox JG, Nambiar PR, Rogers AB. “Agammaglobulinemia and S. aureus botryomycosis in a cohort of related sentinel swiss Webster mice”. J Clin Microbiol 2008; 46 (5): 1881-1884.

  17. Weitzner JM, Dhawan SS, Rosen LB, Sparti P, Resnick L. “Successful treatment of botryomycosis in a patient with acquired immunodeficiency syndrome”. J Am Acad Dermatol 1989; 21 (6): 1312-1314. BOTRIOMICOSISC uTÁn E A

  18. Ahdoot D, Rickman LS, Haghighi P, Heard WU. “Botryomycosis in the acquired immunodeficiency syndrome”. Cutis 1995; 55 (3): 149-152.

  19. Bulengo-Ransby SM, Headington JT, Cantu-Gonzalez G, Rasmussen JE. “Staphylococcal botryomycosis and hyperinmunoglobulin E syndrome in an infant”. J Am Acad Dermatol 1993: 28: 109-11.

  20. Casals M, Campo A, Garcia F, Carrasco MA, Marco V, Aspiole F, Camps A. “Botriomicosis pseudotumoral”. Med Cutan Iber Lat Am 2002; 30: 64-67.

  21. Mehregan DA, Su WP, Anhalt JP. “Cutaneous botryomycosis”. J Am Acad Dermatol 1991; 24: 393-396.

  22. Leibowitz MR, Asvat MS, Kalla AA y cols. “Extensive botryomycosis in a patient with diabetes and chronic active hepatitis”. Arch Dermatol 1981; 117; 739-742.

  23. Schlossberg D, Pandey M, Reddy R. “The Splendore-Hoeppli phenomenon in hepatic botryomycosis”. J Clin Pathol 1998; 51: 399-400.

  24. Katznelsen D, Vawter GF, Foley GE y cols. “Botryomycosis, a complication in cystic fibrosis. Report of 7 cases”. J Pediatric 1964; 65: 525-539.

  25. Harman RR, English MP, Halford M, Saihan EM, Greenham LW. “Botryomycosis: A complication of extensive follicular mucinosis”. Br J Dermatol 1980; 102: 215-222.

  26. Guerra Amaya O, Solari Zerpa L, Guanira Carranza J y cols. “Botryomycosis y strongyloidosis intestinal en un paciente con HTLV-1: Reporte de un caso”. Rev Med Hered 2002; 13: 2.

  27. Moreno-Collado C. “Botriomicosis. Reporte de 7 casos y revisión de la literatura”. Dermatol Rev Mex 1995; 39: 129-136.

  28. Ramírez-Santos A, Aguilar-Besnier M, Sánchez Aguilar D y cols. “Botriomicosis cutánea”. Med Cutan Iber Lat Am 2008; 36 (1): 23-26.

  29. Buckley RH, Lucas ZJ, Hattler BG y cols. “Defective cellular immunity associated with chronic mucocutaneous moniliasis and recurrent staphylococcal botryomycosis; immunological reconstitution by allogenic bone marrow traspant”. Clin Exp Inmunol 1968; 3: 153-169.

  30. Neuhauser EB. “Actinomycosis and botryomycosis”. Postgrad Med 1970; 48: 59-61.

  31. Chu WO, Fruauff A, Rivas R, Donovan V. “Cutaneous botryomycosis: MR findings”. ARJ 1994; 163; 647-648.

  32. Lefell DJ, Brown MD, Swanson NA. “Laser vaporization: a novel treatment of botryomycosis”. J Dermatol Surg Oncol 1989, 15: 703-705.




2020     |     www.medigraphic.com